Aximris XR (oxycodone hydrochloride ER) / IntellipharmaCeutics - LARVOL DELTA

Intellipharmaceutics provides update on FDA advisory committees meeting for Aximris XR (Oxycodone Hydrochloride extended release) an abuse deterrent opioid analgesic for the treatment of moderate to severe pain (Intellipharmaceutics Press Release) - "Intellipharmaceutics International...announced today that that the Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee of the U.S. Food and Drug Administration (FDA) voted to not support the approval of Aximris XR™ (oxycodone extended-release tablets) for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate."

FDA event